Monday, June 21, 2010 9:21:08 AM
The University of Utah Hospital and INTEGRIS Baptist Medical Center in Oklahoma City have successfully implanted additional Levacor(TM) Ventricular Assist Devices (VAD) in the Bridge-to-Transplant (BTT) clinical study. These are the sixth and seventh implants, respectively, with the Levacor VAD since the inception of the BTT clinical study.
FEATURED Envirotech Vehicles Reaffirms Momentum With AZIO AI and Provides Update on Nasdaq Compliance Process • Jan 21, 2026 1:25 PM
Rainmaker Worldwide Expands U.S. Operations With ATMOCELL 5K and R/OCell® Deployments in the Permian Basin • RAKR • Jan 20, 2026 11:15 AM
One World Products Appoints Filmoore Walker as Chief Operating Officer • OWPC • Jan 20, 2026 11:14 AM
OTC Markets Group Welcomes ConnectM Technology Solutions, Inc. to OTCQX • CNTM • Jan 20, 2026 9:45 AM
From Permits to Pouring Gold: The Power of Being Production-Ready • B • Jan 20, 2026 9:00 AM
Rainmaker Worldwide Inc. Announces Settlement Agreement Resolving Legacy Debt Obligation • RAKR • Jan 15, 2026 10:35 AM
